How GearCheck's Contextual Rules Change Your Report
How GearCheck Works
How GearCheck Works
·9 min read

How GearCheck's Contextual Rules Change Your Report

See the difference: what a blood report looks like with versus without contextual interpretation. Before and after examples from real GearCheck analyses.

Article

The single most important distinction GearCheck makes is between a marker result and its interpretation. A number without context is just a number. A number interpreted for who you are is actionable intelligence.

Imagine two people walk into the same lab and get the exact same blood test result. One is a 28-year-old strength athlete on a testosterone cycle. The other is a 60-year-old sedentary woman. The same number means completely different things. Standard lab reports cannot tell the difference. GearCheck can.

Here are five real examples that show how GearCheck's contextual rules transform the same raw result into a completely different interpretation depending on your profile, training, and AAS use.

🔬Example 1: eGFR of 74 mL/min

eGFR is calculated from creatinine. Creatinine is produced by muscle. More muscle means more creatinine, which means lower eGFR. In a strength athlete, an eGFR of 74 is usually normal physiology. The same number in a 65-year-old sedentary woman would genuinely indicate CKD. Context is everything.

eGFR 74 mL/min

MarkerStandard InterpretationGearCheck Interpretation
ResulteGFR 74 mL/mineGFR 74 mL/min
AssessmentStage 2 CKD. Refer to nephrologist.Expected for a strength athlete with high muscle mass.
Priority⚠️ ACTION✅ CONTEXTUAL (no action needed)
Next stepRepeat in 3 months, consider renal ultrasound.Check Cystatin C to confirm. If normal, no follow-up needed.

The contextual rule here is simple but powerful: eGFR from creatinine is unreliable in anyone with above-average muscle mass. The validation marker is Cystatin C, which is independent of muscle. If Cystatin C is normal, kidney function is normal regardless of what the eGFR calculation says. This single rule saves athletes from unnecessary nephrology referrals, anxiety, and invasive tests every single day.

🩺

The Kidney Rule in Practice

Raw Result: eGFR 74, Creatinine 1.3, Cystatin C 0.8
Standard Interpretation

Abnormal kidney function. Stage 2 CKD. Referral to nephrology recommended. Repeat in 3 months.

GearCheck Interpretation

Normal kidney function. Elevated creatinine from muscle mass. Cystatin C confirms healthy kidneys. No action needed.

🔬Example 2: AST of 85 U/L

Strength athletes training 4—6 days per week have chronically elevated AST and ALT from muscle microtrauma. The contextual rule checks CK (muscle damage marker) and GGT (liver-specific marker). If CK is high and GGT is normal, the AST elevation is muscle, not liver. The same AST of 85 in a non-training individual would genuinely warrant a liver workup.

AST 85 U/L

MarkerStandard InterpretationGearCheck Interpretation
ResultAST 85 U/L (ref < 40)AST 85 U/L (ref < 40)
AssessmentElevated liver enzymes. Investigate hepatitis, NAFLD, alcohol use.Post-training muscle enzyme release. Check CK and GGT.
Priority⚠️ ACTION✅ CONTEXTUAL (if CK elevated + GGT normal)
Next stepAbdominal ultrasound, repeat in 2 weeks.5 days off training, retest. AST will drop.

The key insight is that AST and ALT exist in both liver cells and skeletal muscle cells. GGT is found only in the liver. By checking the ratio and the corroborating markers, GearCheck distinguishes muscle leak from liver damage with high accuracy. For the athlete, this means a few days of rest instead of a full liver workup. For the non-athlete with genuinely elevated liver enzymes, it means no delay in diagnosis.

🫀

The Liver vs. Muscle Rule in Practice

Raw Result: AST 85, ALT 72, CK 1200, GGT 28
Standard Interpretation

Elevated liver enzymes. Possible NAFLD or medication-induced hepatotoxicity. Abdominal ultrasound recommended.

GearCheck Interpretation

Muscle enzyme leak from training. CK confirms muscle origin. GGT is normal — liver is healthy. Rest 5 days and retest.

🔬Example 3: HDL of 28 mg/dL

AAS pharmacologically suppress HDL by increasing hepatic lipase activity. An HDL of 28 mg/dL on blast is common and expected. The contextual rule checks whether the user is on cycle and, crucially, whether ApoB is elevated. ApoB is a stronger predictor of cardiovascular risk than HDL in isolation. If ApoB is normal, the low HDL is expected pharmacological noise that does not require intervention.

HDL 28 mg/dL

MarkerStandard InterpretationGearCheck Interpretation
ResultHDL 28 mg/dL (ref > 40)HDL 28 mg/dL (ref > 40)
AssessmentSeverely low HDL. High cardiovascular risk.Expected on AAS. Compare to on-cycle baseline.
Priority⚠️ ACTION🔶 ATTENTION (not ACTION unless ApoB also elevated)
Next stepStart statin or niacin therapy.Check ApoB. If < 110, monitor only. Retest off-cycle.

This is one of the most common scenarios GearCheck handles. Standard labs flag nearly every AAS user's HDL as critically low. But the evidence shows that ApoB is a much better predictor of cardiovascular events than HDL. The contextual rule does not ignore the low HDL — it correctly prioritizes it based on the full lipid picture.

❤️

The Lipid Rule in Practice

Raw Result: HDL 28, LDL 145, ApoB 95, Triglycerides 110
Standard Interpretation

Severely dyslipidemic. High cardiovascular risk. Statin therapy strongly recommended.

GearCheck Interpretation

AAS-typical lipid pattern. ApoB is normal — no intervention needed for HDL alone. Retest off-cycle. Monitor ApoB as primary risk marker.

🔬Example 4: Hematocrit of 54%

This is a case where the contextual rule agrees with the standard interpretation, but for different reasons. A hematocrit of 54% is actionable in both frameworks. However, GearCheck identifies the cause and targets the intervention at the root cause.

Hematocrit 54%

MarkerStandard InterpretationGearCheck Interpretation
ResultHct 54% (ref < 50%)Hct 54% (ref < 50%)
AssessmentErythrocytosis. Risk of thrombosis.AAS-stimulated erythropoiesis. Above 54% requires action.
Priority⚠️ ACTION⚠️ ACTION (same conclusion, different reasoning)
Next stepPhlebotomy, hematology referral.Evaluate dose reduction, consider phlebotomy. Check platelets and blood pressure.

The danger is real either way — a hematocrit above 54% increases blood viscosity and cardiovascular risk regardless of the cause. But the difference matters for treatment. Standard medicine might order a bone marrow biopsy to rule out polycythemia vera. GearCheck recognizes the AAS-stimulated erythropoiesis pattern and targets the intervention at the root cause: dose management, therapeutic phlebotomy if needed, and blood pressure monitoring.

🩸

The Hematology Rule in Practice

Raw Result: Hct 54%, Hb 17.8, RBC 6.1, Platelets 220
Standard Interpretation

Erythrocytosis. Risk of thromboembolic events. Hematology referral for bone marrow biopsy to rule out PV.

GearCheck Interpretation

AAS-stimulated erythropoiesis. Action required. Reduce dose or donate blood. Check BP. No bone marrow biopsy needed unless platelets are also elevated.

🔬Example 5: Creatinine of 1.4 mg/dL

Creatinine reflects muscle mass, protein intake, and training status. A strength athlete weighing 100 kg with high protein intake will naturally have a higher creatinine than a sedentary individual. The contextual rule cross-references Cystatin C, which is independent of muscle mass.

Creatinine 1.4 mg/dL

MarkerStandard InterpretationGearCheck Interpretation
ResultCreatinine 1.4 mg/dL (ref < 1.2)Creatinine 1.4 mg/dL (ref < 1.2)
AssessmentElevated creatinine. Possible kidney impairment.Elevated creatinine secondary to high muscle mass and high-protein diet.
Priority⚠️ ATTENTION✅ CONTEXTUAL (if Cystatin C normal)
Next stepRepeat creatinine, consider nephrology consult.No action needed if Cystatin C and eGFR (Cystatin C) are normal.

This rule alone prevents thousands of unnecessary medical consultations. Creatinine is a poor kidney marker in people with above-average muscle mass, yet standard labs continue to use it as the primary screening tool. The contextual fix is elegantly simple: just check Cystatin C. If it is normal, the kidneys are fine. The "elevated" creatinine is benign physiology.

🩻

The Creatinine Rule in Practice

Raw Result: Creatinine 1.4, eGFR 56, Cystatin C 0.9
Standard Interpretation

Moderately reduced kidney function. eGFR below 60 = Stage 3a CKD. Repeat in 3 months. Nephrology consult if persistent.

GearCheck Interpretation

Benign creatinine elevation from high muscle mass. Cystatin C is normal — kidney function is healthy. No follow-up needed. eGFR by Cystatin C would be > 90.

🧩How the Rules Apply: The Decision Pattern

Each contextual rule follows the same logical pattern. Once you understand the structure, you can apply it to any marker:

1

Identify the Primary Signal

A marker is outside its standard reference range. The standard interpretation would flag it as abnormal. In most cases, this triggers an ACTION or ATTENTION priority. Examples: eGFR 74, AST 85, HDL 28, Hct 54%, Creatinine 1.4.
2

Check the Confounding Factor

Is there a known, non-pathological reason for the deviation? The rule checks user profile data: training status, AAS use, body composition, age. If the confounding factor is present, the rule proceeds to validation. If not, the standard interpretation stands.
3

Validate with a Specificity Marker

A second marker — one that is not affected by the confounding factor — is checked to confirm or refute the hypothesis. This is the crucial step that separates context-aware analysis from guesswork.
Confounded marker
eGFR (creatinine-based)
Specificity marker
Cystatin C (muscle-independent)
Confounded marker
AST (liver + muscle)
Specificity marker
GGT (liver only)
4

Adjust the Priority

Based on the validation, the marker's priority is adjusted. If the specificity marker confirms the hypothesis (e.g., normal Cystatin C = kidneys are fine), the priority drops from ACTION to CONTEXTUAL. If the specificity marker disagrees (e.g., elevated Cystatin C with low eGFR = real kidney problem), the priority stays at ACTION or may even escalate.
📐The Pattern Behind the Rules
🔮

Context Can Flip a Marker in Seconds

These five examples share a common structure: a marker that would trigger "ACTION" in a standard framework is downgraded to "CONTEXTUAL" or adjusted in priority once the right corroborating markers are checked. The contextual rules do not ignore abnormal values. They validate or invalidate them with additional data. The result is an interpretation that is more accurate, less alarming, and more clinically useful than what a standard lab report or general-practitioner review would provide.
🔮

A low eGFR is CKD in one person and normal in another. An elevated AST is liver damage or muscle recovery. Low HDL is a heart attack signal on a standard report and expected pharmacology on cycle. The same number means different things to different people.

GearCheck Contextual Engine
What Context Prevents
  • Unnecessary kidney biopsies for low eGFR
  • Liver workups for training-elevated AST
  • Statins for benign on-cycle LDL elevation
  • Bone marrow biopsies for AAS-induced Hct
What Context Catches
  • Normal eGFR with rising Cystatin C = hidden kidney stress
  • Rising GGT on oral AAS = genuine hepatotoxicity
  • Elevated ApoB with normal LDL = hidden cardiovascular risk
  • Suppressed SHBG with normal T = possible long-term suppression
🔮Bottom Line
Context can flip a marker from ACTION to CONTEXTUAL in seconds. A low eGFR is CKD in one person and normal in another. An elevated AST is liver damage or muscle recovery. Low HDL is a heart attack signal on a standard report and expected pharmacology on cycle. The same number means different things to different people. GearCheck applies 13+ contextual rules automatically so you never have to guess whether your results are real signals or expected noise.

Stay Informed

Get evidence-based blood marker analysis and harm reduction insights delivered to your inbox.

GearCheck provides blood marker analysis and harm reduction education. Our articles are for informational purposes only and do not constitute medical advice. Always consult a healthcare professional before making health decisions.